GARDEN GROVE, California, July 3, 2017 /PRNewswire/ -- HYCOR® Biomedical, a leading manufacturer of in vitro diagnostic products for allergy and autoimmune testing, announced today the addition of key personnel to the company's management team.
HYCOR has strengthened its global team by adding several seasoned executives, including Eric Whitters, Ph. D. as Chief Operating Officer, Tommy Chiu as Vice President of Operations, Ulf Bladin, MBA as Vice President, General Manager for EMEA territory and Kim Walker, MS, FRAPS as Vice President of Regulatory, Quality, and Clinical Affairs.
"We're extremely pleased to add such highly talented and dedicated personnel to both our corporate management team in North America as well as group operations in Europe," said Richard Aderman, Chief Executive Officer at HYCOR. "These additions to our global leadership team bring a breadth of industry experience to help advance the company as we move toward regulatory approvals that will bring cutting edge technology to clinicians and laboratories worldwide."
The new HYCOR executives include:
-- Eric Whitters, Ph. D., Chief Operating Officer, brings more than 22
years of research, development, quality, regulatory and operations
experience from various sources including Fortune 500 organizations and
niche diagnostic companies. Eric has vast experience delivering products
to the U.S. and European marketplaces after leading development teams of
more than eighty (80) assays for the IMMULITE(®), TIGRIS(®),
PANTHER(®) and ECi(®) clinical systems. He has worked across a diverse
spectrum of technologies including Point-of-Care (PoC), serology,
immunochemistry, clinical chemistry & molecular diagnostics and within
diverse disease states such as Allergy, Cardiac, Thyroid, Autoimmune,
Infectious Disease, Sepsis and Anemia.
-- Tommy Chiu, Vice President of Operations, brings a wealth of knowledge
and experience in manufacturing operations refined over 34 years in the
in vitro medical diagnostic industry with experience in international
expansion in the United Kingdom and China. Tommy has worked in various
capacities within manufacturing management and on the leadership team
for Diagnostic Products Corporation(®), which later became Siemens
Healthcare Diagnostics(®). He helped transition the company from a
radioimmunoassay platform to the more innovative chemiluminescence
methodology. In the start-up realm, Tommy helped Astute Medical Inc.(®)
launch its immunoassay for assessing acute kidney injury (AKI) risk in
the U.S. market.
-- Ulf Bladin, Vice President, General Manager for EMEA territory, brings
more than 25 years of diagnostics and pharmaceutical experience
including sales and marketing, strategic positioning and several
successful product launches at Merck Sharp & Dohme(®) and Pfizer(®).
He also played a key role at Phadia(®) as Vice President for Global
Marketing, Scientific and Regulatory Affairs, and Corporate
Communications. After the acquisition of Phadia by Thermo Fisher
Scientific(®) in 2011, Ulf held the position as Vice President
Commercial Operations Europe for the Immuno Diagnostic Division and
member of the global leadership team.
-- Kim Walker, Vice President of Regulatory, Quality and Clinical Affairs,
brings more than 24 years of industry experience across several areas
including clinical lab, blood banking, veterinary, biologics,
pharmaceuticals, devices and IVDs. Prior to joining HYCOR, Kim ran her
own consulting business for 11 years. She also worked for Beckman
Coulter(®) as a Manager, Regulatory Affairs. Kim has participated on
the CLSI Point of Care Testing, Quality Systems, and Process Improvement
working groups. She has been a course developer and instructor for
several graduate and undergraduate regulatory, quality, and clinical
About HYCOR Biomedical
Founded in 1981, HYCOR is a global manufacturer and marketer of in vitro diagnostics products. Since its founding, HYCOR has expanded its presence into urinalysis, allergy and autoimmune products used in clinical laboratories, hospitals and doctors' offices worldwide. Among its products, HYCOR markets the HYTEC(®) and AUTOSTAT(®) brands. The company is focused on delivering products that provide the highest value to clinicians through innovation, reliability and customer service. For more information, please visit www.HYCORbiomedical.com [http://www.hycorbiomedical.com/].
IMMULITE(®) is a trademark of Siemens Healthcare Diagnostics, Inc.
PANTHER(® )is a trademark of Hologic
ECi(®) is a trademark of Ortho Clinical Diagnostics
CONTACT: Elizabeth Fatone, inVentiv Health, Liz.Fatone@inventivhealth.com, Ph: 310-963-5221
Web site: http://www.hycorbiomedical.com/